Debt-to-equity of Keenova Therapeutics plc from 28 Mar 2014 to 26 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Keenova Therapeutics plc quarterly Debt-to-equity in % history and change rate from 28 Mar 2014 to 26 Sep 2025.
  • Keenova Therapeutics plc Debt-to-equity for the quarter ending 26 Sep 2025 was 128%, a 46% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Keenova Therapeutics plc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 128% -109% -46% 26 Sep 2025
Q2 2025 128% -487% -79% 27 Jun 2025
Q1 2025 158% -712% -82% 28 Mar 2025
Q4 2024 194% -652% -77% 27 Dec 2024
Q3 2024 237% -529% -69% 27 Sep 2024
Q2 2024 614% +290% +89% 28 Jun 2024
Q1 2024 870% +618% +245% 29 Mar 2024
Q4 2023 846% +472% +126% 29 Dec 2023
Q3 2023 766% +190% +33% 29 Sep 2023
Q2 2023 325% -628% -66% 30 Jun 2023
Q1 2023 252% -1657% -87% 31 Mar 2023
Q4 2022 374% -1011% -73% 30 Dec 2022
Q3 2022 575% -506% -47% 30 Sep 2022
Q2 2022 953% +58% +6.5% 01 Jul 2022
Q1 2022 1909% +1053% +123% 01 Apr 2022
Q4 2021 1385% +707% +104% 31 Dec 2021
Q3 2021 1081% +513% +90% 24 Sep 2021
Q2 2021 895% +480% +116% 25 Jun 2021
Q1 2021 856% +545% +175% 26 Mar 2021
Q4 2020 678% +406% +149% 25 Dec 2020
Q3 2020 568% +321% +130% 25 Sep 2020
Q2 2020 414% +216% +109% 26 Jun 2020
Q1 2020 311% +141% +83% 27 Mar 2020
Q4 2019 272% +121% +80% 27 Dec 2019
Q3 2019 247% +114% +86% 27 Sep 2019
Q2 2019 198% +52% +36% 28 Jun 2019
Q1 2019 170% +11% +7.2% 29 Mar 2019
Q4 2018 151% -20% -12% 28 Dec 2018
Q3 2018 133% -58% -31% 28 Sep 2018
Q2 2018 146% -48% -25% 29 Jun 2018
Q1 2018 159% -39% -20% 30 Mar 2018
Q4 2017 171% -32% -16% 29 Dec 2017
Q3 2017 192% -13% -6.4% 29 Sep 2017
Q2 2017 194% -15% -7.1% 30 Jun 2017
Q1 2017 198% -5% -2.3% 31 Mar 2017
Q4 2016 204% +17% +9.2% 30 Dec 2016
Q3 2016 205% +32% +19% 30 Sep 2016
Q2 2016 208% +49% +31% 24 Jun 2016
Q1 2016 203% +38% +23% 25 Mar 2016
Q4 2015 187% 0% -0.25% 25 Dec 2015
Q3 2015 173% -32% -16% 25 Sep 2015
Q2 2015 160% -85% -35% 26 Jun 2015
Q1 2015 165% -49% -23% 27 Mar 2015
Q4 2014 187% 26 Dec 2014
Q3 2014 205% 26 Sep 2014
Q2 2014 244% 27 Jun 2014
Q1 2014 214% 28 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.